20 Aralık 2024 Cuma

Targeting Periplakin of Novel Benzenesulfonamides as Highly Selective Agonists for the Treatment of Vitiligo

›
  Vitiligo is the most common cause of depigmentation worldwide, with immunosuppressive treatments often being inefficient and prone to recu...
17 Eylül 2024 Salı

Chicken models aid understanding of human immune diseases (Vitiligo)

›
The article on WATTPoultry.com highlights the use of Smyth line chickens, a breed prone to autoimmune diseases like vitiligo, as an importan...
15 Eylül 2024 Pazar

A Major Breakthrough on the Path to Vitiligo Treatment

›
 Disorganisation of Basement Membrane Zone Architecture Impairs Melanocyte Residence in Vitiligo This study investigates the causes of depig...

Antioxidant mechanisms of mesenchymal stem cells and their therapeutic potential in vitiligo

›
This review article discusses the therapeutic potential of mesenchymal stem cells (MSCs) in treating vitiligo, a skin disorder characterized...
16 Mart 2024 Cumartesi

A NEW VITILIGO TREATMENT?

›
  Ritlecitinib (under the commercial name LITFULO by Pfizer) is an anti-inflammatory and immunosuppressive drug that was recently approved f...

YENİ İLAÇ MI GELİYOR?

›
Ritlecitinib (Pfizer tarafından LITFULO ticari adıyla), yakın zamanda ABD ve Japonya'da şiddetli alopesi areata tedavisi için onaylanan ...
11 Ekim 2023 Çarşamba

Reduced Mortality Associated With Vitiligo

›
The chances of mortality could be low for patients with vitiligo, according to a recent study published in the   Journal of Investigative De...

Vitiligolularda Ölüm Riski Daha Düşük!

›
Kore'de yayınlanan yakın tarihli bir araştırmaya göre, vitiligolu hastalarda ölüm şansı düşük olabilir. Nüfusa dayalı kohort çalışmasınd...
20 Ağustos 2023 Pazar

Newly Discovered Genes Could Change Vitiligo Treatment

›
  A recent study has revealed 135 previously unknown genes that play important roles in regulating melanin production in humans—and that cou...